Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ Gold
search
Subscribe
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ Gold
Subscribe
FREE
Nurturing home-grown innovation in Europe
Europe is a front runner for pharmaceutical research and thought leadership Find out in what measure this is translating into home-grown innovation.
Sanofi and GSK seek COVID-19 vaccine approval
Sanofi and GSK are seeking regulatory approval for their adjuvanted protein-based COVID-19 vaccine, as a primary two-dose series and booster dose.
7
Mins
24 Feb 2022
Evolving the Role for Immunotherapy in Lung Cancer: Extensive-Stage Small Cell Lung Cancer and Unresectable Stage III Non-small Cell Lung Cancer
Lung cancer is classified into NSCLC (85% of patients) and SCLC (15%). NSCLC can be further classified histologically into three main type…
Reacting to supply chain risks
The pharmaceutical supply chain is vulnerable to adverse events, and the pandemic has served as a reminder of how these networks can be tested. The industry has learned tough lessons from COVID-19 that must be translated into modernisation and improvements
Innovative tech, pharma supply chains and more
Marc and Helena chat with Wayne Best, Chief Creative Officer, VMLY&R, about his ‘I Will Always Be Me’ project for patients with motor neurone disease. Listen now!
22 Feb 2022
EULAR Podcast Highlights: COVID-19, rheumatoid arthritis and ankylosing spondylitis
A review of the latest and most pertinent information from EULAR 2021 regarding COVID-19 for patients with rheumatic musculoskeletal…
22 Feb 2022
EULAR Podcast Highlights: Latest treatment options for Psoriatic Arthritis
The novel data presented at EULAR 2021 highlights the latest treatment options and safety aspects for patients with psoriatic arthritis…
Spoonful of technology: February 2023
GOLD reviews the top stories in health technology from the past few months, highlighting how tech is changing treatment landscapes and patient experiences.
21 Feb 2022
Disability and Death Risk Increased in COVID-19-Associated Stroke
Many patients with COVID-19 present at the hospital with symptoms of acute ischaemic stroke, caused by a sudden blockage of blood flow…
21 Feb 2022
Could Smartphones Diagnose and Track Neurological Conditions?
Allow neurologists and patients to capture important clinical data using readily available technology, such as smartphones and tablets…
←
1
2
3
…
749
750
751
752
753
754
755
…
1,300
1,301
1,302
→
We’ve noticed you’re accessing
from
North/South America.
View
View